CD8A and pulmonary emphysema: Among the components of chronic obstructive pulmonary disease (COPD), which include emphysema and airway disease, emphysema enhances the therapeutic effect of PD-L1 blockade by exhausting the early cytotoxic CD8+ T cells6.